ANDA 77166, held by PharmoBedient. Venlafaxine Hydrochloride.
As of Nov 20, 2026, ANDA 77166 (Venlafaxine Hydrochloride), held by PharmoBedient, was first approved by FDA on Jun 13, 2008, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 13, 2008 | Original application | Approved | None posted |
| Venlafaxine HydrochlorideEQ 25MG BASE · tablet;oral | Venlafaxine Hydrochloride | Discontinued |
| Venlafaxine HydrochlorideEQ 37.5MG BASE · tablet;oral | Venlafaxine Hydrochloride | Discontinued |
| Venlafaxine HydrochlorideEQ 50MG BASE · tablet;oral | Venlafaxine Hydrochloride | Discontinued |
| Venlafaxine HydrochlorideEQ 75MG BASE · tablet;oral | Venlafaxine Hydrochloride | Discontinued |
| Venlafaxine HydrochlorideEQ 100MG BASE · tablet;oral | Venlafaxine Hydrochloride | Discontinued |
| Aug 18, 2023 | Supplement 20Labeling · Standard review | Approved | None posted |
| Sep 20, 2021 | Supplement 18Labeling · Standard review | Approved | None posted |
| Apr 14, 2020 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jan 4, 2017 | Supplement 16Labeling · Standard review | Approved | None posted |
| Feb 2, 2016 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jul 17, 2014 | Supplement 14Labeling · Standard review | Approved | None posted |
| Jul 7, 2014 | Supplement 11Labeling · Standard review | Approved | None posted |
| Jul 7, 2014 | Supplement 13Labeling · Standard review | Approved | None posted |
| Jan 30, 2011 | Supplement 8Manufacturing | Approved | None posted |
| Sep 27, 2010 | Supplement 7Labeling | Approved | None posted |
| Jul 23, 2009 | Supplement 1Labeling | Approved | None posted |
| Jun 13, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters